Hemispherx BioPharma (HEB)

[drkazmd65]

To my (outsider) knowledge - Alferon has not yet been approved by the FDA.

Doesn't mean that the insiders (being insiders after all) don't know something that we all don't know as yet.

I suspect that the favorable analysts reviews are due to a combination of publically known factors that include:

1) The fact that HEB's drug was apparently extremely effective against Ebola virus in mouse models when tested this last Winter.

2) The investments that the company has been making in upgrading their Alferon manufacturing facility, that 'should' lead to the facility being much more cost-effective and efficient at producing Alferon sometime in the next 9-12 months.

3) The experimental data (even though the FDA hasn't greenlighted it yet) that suggests that - at least for some patients - Ampligen can provide relief from Chronic Fatigue Syndrome.

But these are just guesses, and mostly are spelled out in the Arrowhead analysis document - so hard to know if the insiders know something else that we don't know (yet).